Unravelling the rate of action of hits in the Leishmania donovani box using standard drugs amphotericin B and miltefosine

Open Access

Peer-reviewed

Research Article

Diana Tegazzini,

Current address: European Screening Centre, University of Dundee, Biocity Scotland, Newhouse, United Kingdom

Affiliation Kinetoplastids DPU, Diseases of the Developing World (DDW), GlaxoSmithKline, Tres Cantos, Madrid, Spain
⨯
Juan Cantizani,

Affiliation Kinetoplastids DPU, Diseases of the Developing World (DDW), GlaxoSmithKline, Tres Cantos, Madrid, Spain
⨯
Imanol Peña,

Affiliation Kinetoplastids DPU, Diseases of the Developing World (DDW), GlaxoSmithKline, Tres Cantos, Madrid, Spain
⨯
Julio Martín,

Affiliation Kinetoplastids DPU, Diseases of the Developing World (DDW), GlaxoSmithKline, Tres Cantos, Madrid, Spain
⨯
Jose M. Coterón

* E-mail: jose.m.coteron@gsk.com

Affiliation Kinetoplastids DPU, Diseases of the Developing World (DDW), GlaxoSmithKline, Tres Cantos, Madrid, Spain
⨯

Reader Comments (0)

Leishmania donovani
Is the Subject Area "Leishmania donovani" applicable to this article?

Thanks for your feedback.
Drug discovery
Is the Subject Area "Drug discovery" applicable to this article?

Thanks for your feedback.
Amphotericin
Is the Subject Area "Amphotericin" applicable to this article?

Thanks for your feedback.
Amastigotes
Is the Subject Area "Amastigotes" applicable to this article?

Thanks for your feedback.
Drug screening
Is the Subject Area "Drug screening" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Parasitic diseases
Is the Subject Area "Parasitic diseases" applicable to this article?

Thanks for your feedback.
Kinetoplastids
Is the Subject Area "Kinetoplastids" applicable to this article?

Thanks for your feedback.